Korea Stocks, page 10 of 36 — 24 articles published 2026-08-30 ~ 2026-09-02.
Heerim Architects and Planners (KOSDAQ 037440) 2026 stock outlook. A deep qualitative look at its architecture design, CM and supervision model, Middle East airport and stadium order momentum, backlog-driven revenue recognition, thin margins of a people-heavy service business, and FX and geopolitical order-cycle risk for global investors.
Eugene Investment and Securities (KOSPI 001200) 2026 stock outlook. A deep look at how retail brokerage, bond trading and real-estate project-finance exposure create earnings leverage, why the low PBR is both an opportunity and a trap, and what U.S. investors should watch on FX and taxes.
Hwanggeum ST (032560) stock outlook for 2026. A qualitative deep dive into its stainless steel distribution and processing business, nickel-driven inventory swings, the large real estate and investment assets that make it a classic Korean deep-value asset play, and what it would take for the discount to close.
Korea Alcohol Industrial (KOSDAQ 017890) 2026 stock outlook. A qualitative deep dive into the protected soju-ethanol oligopoly, ethyl acetate and anhydrous ethanol cyclicality, grain and molasses cost pass-through, and the bioethanol optionality for foreign investors.
Yuseong Enterprise 002920 stock outlook 2026: piston rings, cylinder liners and camshafts as an internal-combustion cash cow, captive Hyundai-Kia supply ties, the structural EV-transition demand risk, and how a long labor-dispute history drives the valuation discount.
A 2026 stock outlook for Kyung Chang Industrial (KRX 002420), the Korean auto-parts maker behind transmission components, control cables and pedals for Hyundai and Kia. We weigh the structural decline of transmission parts against cables, electronic pedals and EV reduction-gear opportunities, plus OEM production-cycle risk, thin margins and the deep-value case.
A 2026 outlook on Korea Cosmetics Manufacturing (003350): why it is a cosmetics ODM and OEM manufacturer rather than a brand, how it differs from the separately listed seller Korea Cosmetics (123690), the reality of K-beauty export spillover, small-float volatility, peer comparison, and a practical playbook for investors.
Daea TI (045390) 2026 stock outlook. A plain-English breakdown of the rail signaling and traffic-control SI model, the KTCS and LTE-R localization moat, the GTX and aging-equipment replacement tailwind, and the risks of public-order dependence, thin competitive bids, and theme-stock volatility.
KCTC (KRX 009070) 2026 stock outlook. A qualitative deep dive into its port stevedoring, third-party logistics (3PL) and heavy-cargo project business, container and bulk throughput cycles, wage and fuel margin pressure, its low-PBR asset base, competition with CJ Logistics, Hanjin, Sebang and Dongbang, plus practical scenarios and tax notes for foreign investors.
Air Busan (298690) stock outlook for 2026. A deep qualitative look at the regional low-cost carrier's cost model, the Korean Air-Asiana merger that folds Jin Air, Air Seoul and Air Busan into one combined LCC, minority-shareholder risk, fuel and FX sensitivity, and the travel-demand recovery.
Namsun Aluminum (KRX 008350) 2026 stock outlook for global investors. A qualitative deep dive into the aluminum extrusion core business (construction window frames and curtain walls plus automotive lightweighting parts), its place inside the SM Group, the materials cycle and construction and auto end-markets, and the extreme volatility that comes from being one of Korea's best-known political-theme stocks.
Hanyang Securities (001750) 2026 stock outlook. A qualitative deep dive into this small-cap Korean brokerage: its fixed-income and niche IB model, the Hanyang University foundation stake sale and change of control, its deep-value dividend appeal, and the real estate PF and liquidity risks investors must weigh.
SIMPAC (KRX: 009160) 2026 investment analysis. Press and forging machinery segment, ferroalloy and special steel materials, automotive and shipbuilding capex cycle exposure, low-PBR asset value, spread economics, peer comparison, and risk framework for global investors.
A qualitative 2026 stock outlook for Hyundai Pharm (KRX 004310), the veteran Korean drugmaker behind both a broad ethical-drug portfolio and Mieero Fiber, its decades-old consumer fiber drink. We cover the twin-engine business model, incremental drug pipeline, the low-PBR asset case, owner succession as a re-rating catalyst, drug-price and generic-competition risks, and how global investors should frame the KRW-listed shares.
SGC Energy (KRX: 005090) 2026 stock outlook. A qualitative deep-dive into its Gunsan district-energy cogeneration and power sales, solar and renewables option, the fuel-cost spread that drives quarterly margins, and the SGC Group holding-company character (SGC E&C construction and SGC Solution glass) that makes it a low price-to-book asset play with real discounts attached.
KG Mobilians (046440) stock outlook 2026: a deep, qualitative look at how this Korean payments company is stretching its mature mobile carrier billing cash flow into full-service PG and simple-pay expansion, KG Group synergies, and Korea's card-fee regulation risk.
SMEC (099440) 2026 stock outlook: KOSDAQ-listed Korean machine tool maker's CNC lathe and machining center cash flow, its push into collaborative robots and smart factory automation, Chinese machine tool competition, capex cycle exposure, and foreign investor access via KRX brokers.
OPENEDGES Technology (394280) 2026 stock outlook. A qualitative deep dive into its on-chip memory controller, NPU and interconnect semiconductor IP licensing-plus-royalty model, comparison with ARM and Rambus, on-device AI demand leverage, and the unresolved path to sustained profitability.
PSK Holdings (031980) 2026 stock outlook. A Korean holding company whose value rests on its controlling stake in PSK Inc (319660), the dry-strip and photoresist-removal front-end equipment maker, leveraged to the memory capex cycle and HBM etch demand but weighed down by a persistent parent-subsidiary holding discount, analyzed qualitatively for US investors.
JW Holdings (096760) 2026 stock outlook. A deep qualitative look at Korea's IV-fluid oligopoly moat, JW Life Science and JW Bioscience subsidiary leverage, the gout and oncology pipeline, holding-company NAV discount, and drug-pricing risk for the JW Pharmaceutical group.
KBI Metal (024120) stock outlook for 2026. A close look at its wire, magnet-wire (winding), and auto-parts businesses, why the copper conversion spread matters more than the copper price, its leverage to grid and EV-motor demand, and what would trigger a re-rating of this low-PBR Korean materials stock.
Daemyung Energy (389260) 2026 stock outlook. A qualitative deep dive into its wind and solar EPC track record, recurring O&M revenue, owned generation-asset cash flow, RPS and REC policy sensitivity, interest-rate exposure, and project-pipeline execution risk for the KOSDAQ developer.
Chong Kun Dang Holdings (KRX: 001630) 2026 stock outlook. A qualitative deep dive into the pharmaceutical holding-company NAV discount, the earnings leverage from subsidiaries Chong Kun Dang, Kyongbo Pharm, CKD Bio and CKD Health, how the holdco differs from operating company Chong Kun Dang (185750), plus dividend appeal and owner-governance risk.
Interflex (051370) 2026 stock outlook. A qualitative deep dive into its flexible printed circuit board (FPCB) supply to Samsung Display OLED and Samsung Electronics smartphones, single-customer concentration risk, Chinese low-cost competition, OLED and automotive expansion leverage, plus US-investor tax and FX considerations.